The present invention is directed to compounds which inhibit prenyl-protein transferase and particularly, the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras.

 
Web www.patentalert.com

< (none)

< Anti-inflammatory pharmaceutical formulations

> Rapidly disintegrating solid oral dosage form

> (none)

~ 00030